Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.
News for Inogen Inc (INGN) centers on its activities as a medical technology company focused on respiratory products for homecare use. This page aggregates company press releases, earnings announcements, product launches, and other public updates that Inogen provides to investors, patients, and partners.
Inogen regularly issues quarterly financial results and outlook updates, detailing revenue by sales and rental categories, business-to-business and direct-to-consumer performance, gross margin trends, operating expenses, and non-GAAP measures such as EBITDA and adjusted EBITDA. These releases often highlight factors driving performance, such as demand from domestic and international business-to-business customers and changes in direct-to-consumer and rental revenue.
Product-related news is another key theme. Recent announcements include the launch of the Voxi 5 stationary oxygen concentrator, designed to expand access to oxygen therapy for long-term care patients in the United States, and the introduction of Aurora CPAP masks for patients with obstructive sleep apnea. Such updates illustrate how Inogen is broadening its respiratory care portfolio beyond portable oxygen concentrators into stationary oxygen therapy and sleep-therapy accessories.
Corporate and leadership developments, such as technology and executive appointments, also appear in Inogen’s news flow, offering context on how the company is organizing around digital health, connected devices, and operational execution. Investors and observers can use this news page to follow Inogen’s financial trajectory, portfolio evolution, and strategic priorities in home respiratory and sleep care.
For anyone tracking INGN stock, revisiting this page provides a consolidated view of Inogen’s latest earnings releases, conference call announcements, and product milestones, all drawn from the company’s own public communications.
Inogen, a medical technology company known for innovative respiratory products, will present at the 20th Annual Needham Virtual Healthcare Conference on April 12, 2021. President and CEO Nabil Shabshab and CFO Alison Bauerlein will host the presentation at 10:15 a.m. ET. Interested parties can access the webcast on Inogen's Investor Relations website, with a replay available for 90 days following the event. Inogen specializes in portable oxygen concentrators designed for long-term supplemental oxygen therapy in homecare settings.
Inogen, Inc. (NASDAQ: INGN), a medical technology company, announced its participation in the KeyBanc Life Sciences & MedTech Investor Forum. The presentation is scheduled for March 23, 2021, at 3:30 p.m. ET, featuring President and CEO Nabil Shabshab, and CFO Alison Bauerlein. Interested individuals can access the webcast on Inogen's Investor Relations page. The company emphasizes transparency by utilizing its website to disclose non-public material information in compliance with Regulation FD. Inogen develops innovative portable oxygen concentrators for patients with chronic respiratory conditions.
Inogen, a medical technology company, reported Q4 2020 revenue of $74 million, down 6.3% year-over-year, primarily impacted by COVID-19. Domestic B2B sales rose 17.9% to $24.2 million, while rental revenue surged 71.7% to $9.4 million. The company incurred a net loss of $5.1 million and had cash reserves of $231.2 million with no debt. For 2021, Inogen refrained from providing financial guidance due to market uncertainties but anticipates improvements in domestic sales and rental revenue despite expected declines in international and direct-to-consumer sales.
Inogen, Inc. (NASDAQ: INGN) announced the appointment of Kristen Miranda to its Board of Directors, effective March 1, 2021, filling the vacancy left by Scott Beardsley’s resignation. Miranda brings extensive healthcare experience, having served as Aetna’s West Region President since 2017. Her addition aims to enhance payor acceptance of Inogen’s products. CEO Nabil Shabshab emphasized her healthcare background as a key asset for expanding patient access and enhancing shareholder value. The company continues to focus on innovative respiratory solutions for homecare settings.
Inogen, Inc. (NASDAQ: INGN) announced its participation in the 10th Annual SVB Leerink Healthcare Conference, scheduled for February 25, 2021. CEO Nabil Shabshab and CFO Alison Bauerlein will present at 2:20 p.m. ET. The presentation can be accessed via the Investor Relations page on Inogen's website, with a replay available for 90 days post-event. Inogen focuses on developing innovative respiratory products, particularly portable oxygen concentrators for patients with chronic respiratory conditions.
Inogen, Inc. (Nasdaq: INGN) will release its fourth quarter and year-end 2020 financial results on February 24, 2021, after market close. Following the release, a conference call will be held at 1:30 PM PT/4:30 PM ET, where investors can participate by calling (877) 841-3961 domestically or (201) 689-8589 internationally. A replay will be available from February 24, 2021, at 3:30 PM PT until March 10, 2021. Inogen specializes in respiratory products, particularly portable oxygen concentrators for patients with chronic respiratory conditions.
Inogen, Inc. (NASDAQ: INGN) has appointed Nabil Shabshab as President and CEO, effective February 8, 2021, succeeding Scott Wilkinson, who is retiring. Shabshab brings extensive experience from Becton Dickinson, where he served as Worldwide President of Diabetes Care. The Board expressed confidence in Shabshab's leadership to drive growth and enhance patient access to innovative respiratory products. Inogen is recognized for its portable oxygen concentrators aimed at improving the lives of respiratory therapy patients.
Inogen, Inc. (NASDAQ: INGN) has announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. The Company’s President and CEO, Scott Wilkinson, along with CFO, Alison Bauerlein, will present on January 12, 2021, at 5:20 p.m. EST. Investors can access a live audio webcast through Inogen's Investor Relations page, with a replay available for 90 days post-event. Inogen specializes in developing and marketing portable oxygen concentrators for patients with chronic respiratory conditions, emphasizing its commitment to innovation in homecare respiratory products.
Inogen (NASDAQ: INGN) announced participation in the Stifel 2020 Virtual Healthcare Conference, where President and CEO Scott Wilkinson, along with CFO Alison Bauerlein, will present on November 17, 2020, at 4:00 p.m. EST. Interested parties can access the live audio webcast via Inogen's Investor Relations page. A replay will be available after the live event for 90 days. Inogen specializes in innovative respiratory products, primarily portable oxygen concentrators for patients with chronic respiratory conditions.
Inogen, Inc. (NASDAQ: INGN) reported Q3 2020 financial results, showing total revenue of $74.3 million, a 19.0% decline year-over-year, primarily attributed to the COVID-19 pandemic. Sequentially, revenue grew by 3.7%. Rental revenue increased by 40.1% to $7.5 million. The company faced a net loss of $1.7 million and an operating loss of $2.0 million. As of September 30, 2020, cash and equivalents stood at $220.5 million with no debt. The company anticipates ongoing adverse impacts from COVID-19 into Q4 2020, with revenue expected to decline compared to Q3.